Concepedia

P NADLER

PN

Statistics

Publications

2

Citations

44

H-Index

2

Active since

2004

Affiliations

National Institute of Dental and Craniofacial Research(Current)

The University of Texas Health Science Center at Tyler

Harvard University

PDL BioPharma (United States)

University of Alabama at Birmingham

P NADLER is an author at National Institute of Dental and Craniofacial Research specializing in monoclonal antibodies, treatment of cytomegalovirus infection, and cytomegalovirus infection management.

Publications per year

2004–2004

2

Publications

2

A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis

Michael J. Borucki, John Spritzler, David M. Asmuth et al. · Antiviral Research · 2004 · 33 citations

Life Sciences, Immunology, Infectious Diseases +16

A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis

Michael J. Borucki, John Spritzler, David M. Asmuth et al. · Antiviral Research · 2004 · 11 citations

Life Sciences, Immunology, Infectious Diseases +16

1–2 of 2